Skip to content

Noninvasive Brain Stimulation to Enhance Cognition at Home Following a TBI.

Enhancing Cognition After TBI Using Noninvasive Vagus Nerve Stimulation at Home

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07428980
Enrollment
7
Registered
2026-02-24
Start date
2026-01-09
Completion date
2026-04-27
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TBI Traumatic Brain Injury

Keywords

Traumatic Brain Injury, Vagus Nerve, Executive Functions, Transcutaneous Vagus Nerve Stimulation (tVNS)

Brief summary

The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous vagus nerve stimulation (tVNS) at home, to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).

Detailed description

This is a single-blind, open-label pilot study to evaluate the feasibility and preliminary efficacy of remotely supervised, at-home delivery of tVNS in individuals with moderate to severe TBI during the post-acute recovery phase. Eligible participants will complete a 2-week tVNS intervention protocol at home. Mixed methods (quantitative and qualitative) will be used to evaluate outcomes. Eligible participants will be invited to initial baseline assessment and tVNS training session (Visit 1). Then, they will complete two weeks of at-home administration period. Lastly, they will return to a post- stimulation assessment (Visit 2). In the assessment sessions participants will complete tasks of set shifting and working memory, core executive functions, as well as complete surveys regarding fatigue, sleep, and overall quality of life.

Interventions

tVNS stimulation, one hour a day, for 14 days.

Sponsors

Shirley Ryan AbilityLab
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-75 years. * Formally diagnosed with traumatic brain injury. * Ability to independently use a keyboard. * Able to understand and communicate in English (according to clinical judgment). * Able to independently provide consent to participate.

Exclusion criteria

* Acute medical issues requiring close physician or nursing monitoring. * Bioelectrical implants, cerebral shunts, including pacemakers. * Anyone with sore or diseased skin area in the ear * Pregnancy or persons who are lactating. * Cardiac arrhythmia. * Epilepsy or seizure disorders. * Significant gross or fine motor weakness. * Significant, ongoing communication or comprehension impairments (such as aphasia) that would affect an individual's ability to complete the required assessments. * Severely impaired memory retention (Score lower than 3 in the 3 Word Delayed Recall test attached to this submission). * Current major depression diagnosis.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who successfully completed 75% of the sessions.Day 15Recording the number of participant who completed at least 75% of the sessions out of the number of participants enrolled in the study.
Participant-Reported Acceptability of Home-Based tVNS TherapyDay 0 and Day 15Completion of the Treatment Acceptability/Adherence Scale at baseline (day 0) and post stimulation assessment (day 15)

Secondary

MeasureTime frameDescription
N-Back taskDay 0 Baseline and Day 15 Post Stimulation AssessmentIn the N-Back Task, participants are presented a series of visual stimuli. They are asking for each stimulus whether is matches a stimulus n-trials before. For example, in a 2-back task, in which the trials consist of letters, participants have to decide whether the current letter is the same as the letter in the trial n-2. We will use a computerized version of this task.
California Verbal Learning TestDay 0 Baseline and Day 15 Post Stimulation AssessmentThe California Verbal Learning Test evaluates the ability to encode, recall, and recognize verbally presented information across multiple learning trials and delayed recall conditions. Participants are read multiple lists of words and asked to recall specific words at different time allotments.
Trail Making Test A&BDay 0 Baseline and Day 15 Post Stimulation AssessmentTrail Making Part A requires participant to draw a line between circles containing numbers in ascending order. Part B requires participants to alternate drawing a line between ascending letters and numbers. The key measures are the time required to complete and the number of errors made in Part A and Part B. The test measures various aspects of cognition including attention, visual search, motor coordination, reasoning, and task switching.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026